Endocrinology, Diabetes and Metabolism
1133 articles · 42 journals
Journals in this subcategory (42)
- AACE Endocrinology and Diabetes · Elsevier (87)
- Diabetes, Obesity and Metabolism · Wiley (81)
- Endocrine Practice · Elsevier (79)
- Bone · Elsevier (70)
- Pancreatology · Elsevier (70)
- Diabetes Epidemiology and Management · Elsevier (68)
- Nutrition · Elsevier (66)
- Endocrinology & Metabolism Clinics of North America · Elsevier (54)
- The Journal of Nutritional Biochemistry · Elsevier (52)
- Endocrinología, Diabetes y Nutrición · Elsevier (50)
- Bone Reports · Elsevier (48)
- Nutrition Research · Elsevier (46)
- Metabolism · Elsevier (44)
- Endocrine and Metabolic Science · Elsevier (40)
- Endocrinology, Diabetes and Metabolism · Wiley (40)
- Obesity Research & Clinical Practice · Elsevier (38)
- Journal of Clinical Densitometry · Elsevier (35)
- Cytokine & Growth Factor Reviews · Elsevier (34)
- Growth Hormone & IGF Research · Elsevier (34)
- Best Practice & Research Clinical Endocrinology & Metabolism · Elsevier (30)
- Nature Reviews Endocrinology · Springer Nature (11)
- Journal of Clinical Hypertension · Wiley (9)
- Journal of Clinical and Translational Endocrinology · Elsevier (9)
- Journal of Diabetes · Wiley (9)
- International Journal of Obesity · Springer Nature (8)
- International Journal of Obesity Supplements · Springer Nature (8)
- npj Metabolic Health and Disease · Springer Nature (8)
- Clinical Obesity · Wiley (5)
- Acta Diabetologica · Springer Nature (0)
- BMC Endocrine Disorders · Springer Nature (0)
- BMC Nutrition · Springer Nature (0)
- Cardiovascular Diabetology · Springer Nature (0)
- Cardiovascular Diabetology – Endocrinology Reports · Springer Nature (0)
- Current Osteoporosis Reports · Springer Nature (0)
- Endocrine · Springer Nature (0)
- Hormones · Springer Nature (0)
- Journal of Bone and Mineral Metabolism · Springer Nature (0)
- Journal of Diabetes & Metabolic Disorders · Springer Nature (0)
- Journal of Endocrinological Investigation · Springer Nature (0)
- Osteoporosis International · Springer Nature (0)
- Pituitary · Springer Nature (0)
- Reviews in Endocrine and Metabolic Disorders · Springer Nature (0)
-
Can a Single Maximally Fortified Food Improve Glycaemia in Type 2 Diabetes? Randomised Crossover Trial of High‐Fibre High‐Protein Bread
ABSTRACT Objective To examine the effects of a maximally fortified high‐fibre high‐protein bread on glycaemia in free‐living adults with Type 2 diabetes. Research Design and Methods Participants were provided commercially produced...
-
Beyond the Scale: Psychological and Behavioural Considerations Following GLP‐1 Receptor Agonist Treatment Discontinuation
Diabetes, Obesity and Metabolism, EarlyView.
-
Cardiometabolic, Physiological and Objective‐Sleep Responses to Transcendental Meditation: Secondary Analysis of a Randomised Controlled Trial Among University Staff
ABSTRACT Background and Aims Chronic stress contributes to cardiometabolic risk, and stress‐reduction interventions have been proposed to improve stress‐sensitive physiology and cardiometabolic health, though evidence remains...
-
Correction to ‘Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta‐Analysis’
Diabetes, Obesity and Metabolism, EarlyView.
-
Association Between Weight Loss on Incretin‐Based Therapy and Cardiovascular Outcomes and Mortality: A Systematic Review and Meta‐Regression
ABSTRACT Aims The primary aim was to evaluate, using aggregate‐data meta‐regression, whether body weight loss induced by incretin mimetic therapy is associated with reductions in three‐point major adverse cardiovascular events ( 3P ‐...
-
Body Mass Index, Cardiometabolic Treatment Patterns and Multifactorial Risk‐Factor Control in Chinese Adults With Type 2 Diabetes: A Multicenter Cross‐Sectional Study
Journal of Diabetes, Volume 18, Issue 11, November 2026.
-
Association Between Amino Acid Levels and Thyroid Function Among Iranian Adults: A Cross‐Sectional Analysis of Bushehr Elderly Health (BEH) Program
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
-
Association of Dietary Insulin Index and Load With Glucose Homeostasis Markers, C‐Peptide and Novel Metabolic Indices (TyG‐BMI and METS‐IR) in Physically Active Young Population
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
-
Complication Prevention Beyond Glycaemic Control in Type 2 Diabetes: Cumulative Metabolic Exposure, Organ Vulnerability and Treatment Durability
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
-
Association Between Cholesterol‐HDL‐Glucose (CHG) Index and New‐Onset Hypertension Across Different Sex and Glycemic Status: A Longitudinal Study With 9‐Year Follow‐Up
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
-
Bleeding and Thromboembolic Outcomes Following GLP‐1 Receptor Agonist Initiation in Patients With Type 2 Diabetes and Atrial Fibrillation Receiving Direct Oral Anticoagulants: A Target Trial Emulation
ABSTRACT Aims Patients with atrial fibrillation (AF) and Type 2 diabetes (T2D) require coordinated stroke prevention and metabolic risk management. Direct oral anticoagulants (DOACs) are standard for stroke prevention, while...
-
Early Changes in Peripancreatic Mesenteric Fat Beyond Weight Loss Predict Durability of Hepatic Improvements in MASLD
ABSTRACT Aims Various visceral adipose tissue depots exhibit heterogeneous metabolic properties. This study aims to explore whether specific abdominal fat compartments differentially predict loss of sustained treatment response to...
-
β‐Cell Recovery Patterns With Initial Combination Versus Stepwise Therapy in Newly Diagnosed Type 2 Diabetes: TRIPLE‐AXEL Post Hoc Analysis
ABSTRACT Background Early intensive therapy may preserve β‐cell function in newly diagnosed Type 2 diabetes mellitus (T2DM), but whether different early treatment strategies produce distinct patterns of β‐cell functional recovery...
-
Reproductive Outcome Registration in Phase 3 Weight‐Management Pharmacotherapy Trials: A Cross‐Sectional Meta‐Research Study
ABSTRACT Aims To quantify registered reproductive outcome measures in women and men in adult Phase 3 weight‐management pharmacotherapy trials and compare them with registered body‐composition measures. Materials and Methods...
-
Correction to ‘Young Adults With Nonalcoholic Fatty Liver Disease, Defined Using the Fatty Liver Index, Can Be at Increased Risk of Myocardial Infarction or Stroke’
Diabetes, Obesity and Metabolism, EarlyView.
-
Exploring Corresponding Cutpoints for Hypoglycaemia Awareness Questionnaire (HypoA‐Q) Impaired Awareness Subscale in Relation to the Gold and Clarke Measures: A Post Hoc Analysis From the Hypo‐METRICS Study
ABSTRACT Aims The Hypoglycaemia Awareness Questionnaire–Impaired Awareness subscale (HypoA‐Q/IA) was developed to enhance impaired awareness of hypoglycaemia (IAH) assessment, addressing methodological deficiencies of the established...
-
Glucagon‐Like Peptide‐1 Receptor Agonists in Type 1 Diabetes: The Importance of Identifying the Insulin‐Resistant Type 1 Diabetes Phenotype, and Differentiating Early and Newer Generation Therapies
Diabetes, Obesity and Metabolism, EarlyView.
-
Correction to ‘Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐METRICS Study’
Diabetes, Obesity and Metabolism, EarlyView.
-
Semaglutide, Tirzepatide and Clinically Recorded Alcohol‐Related Outcomes in Type 2 Diabetes: A Target Trial Emulation
ABSTRACT Aims To compare the risk of incident alcohol use disorder (AUD) among adults with Type 2 diabetes (T2D) initiating semaglutide, tirzepatide or sodium‐glucose cotransporter‐2 inhibitors (SGLT2i). Materials and Methods We...
-
Dose–Exposure–Response Analysis of Finerenone on Serum Potassium and Cardiovascular Outcomes Among Patients With Heart Failure: Insights From FINEARTS‐HF
ABSTRACT Background Finerenone reduces the risk of heart failure and cardiovascular (CV) death among patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). Whether the effects of finerenone to...
-
Closed‐Loop Insulin Delivery in Inpatient Care: A Systematic Review and Meta‐Analysis of Clinical and Implementation Outcomes
ABSTRACT Aims Closed‐loop (CL) insulin delivery systems have transformed outpatient diabetes care. However, evidence supporting their role in inpatient settings is limited. This systematic review and meta‐analysis evaluated the safety,...
-
Therapeutic Signals Without Histologic Certainty: FGF Analogues in Compensated MASH Cirrhosis—A Systematic Review and Meta‐Analysis
ABSTRACT Background and Aims Compensated MASH cirrhosis is an advanced disease with no current approved pharmacologic therapy. FGF analogues have shown biological activity, but individual trials have not established histologic efficacy....
-
Prevalence of Chronic Complications After Inaugural Admission in Intensive Care Unit for Type 1 Diabetes in the SFDT1 Cohort: The INAUGURAL Study
Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11936-11945, December 2026.
-
Accuracy and Safety of the LinX Continuous Glucose Monitoring System in Adults With Diabetes: A Prospective Multicentre Open‐Label Clinical Performance Study
Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11927-11935, December 2026.
-
Potential Associations Between GLP‐1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence
Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 12004-12008, December 2026.
-
Urban Burden Index–Multidomain Assessment of Integrated Obesogenic Risk (UBI‐MAIOR) and Obesity Prevalence Across 10 Metropolitan Areas: An Exploratory Pilot Analysis
Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11999-12003, December 2026.
-
Glucagon‐Like Peptide‐1 Medicines and Risk of Dysaesthesia: A Systematic Review, Meta‐Analysis and Meta‐Regression of Randomised Controlled Trials
Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11994-11998, December 2026.
-
Glucagon‐Like Peptide‐1 Receptor Agonist Use Is Associated With Improved Lung Function in Cystic Fibrosis‐Related Diabetes
Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11986-11989, December 2026.
-
Trends in GLP‐1‐Based Therapy Use Before and After Pregnancy
Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11978-11982, December 2026.
-
Pre‐Bedtime Whey Protein Ingestion Increases Blood Glucose Overnight in Adults With Type 1 Diabetes
Diabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11983-11985, December 2026.